Fosun International Limited: Company Profile and SWOT Analysis

Document Sample
Fosun International Limited: Company Profile and SWOT Analysis Powered By Docstoc
					Fosun International Limited

_________________________________________________________________________________



Fosun International Limited                                                    Financial Snapshot

                                                                               Operating Performance
Fast Facts
                                         No. 2 East Fuxing Road, Shanghai,     The company reported revenue of US$6,584.62
Headquarters Address
                                         200010,People's Republic of China     million during the fiscal year 2010 (2010). The
                                                                               company's revenue grew at a CAGR of 21.35%
Telephone                                + 81332447196
                                                                               during 2006–2010, with an annual growth of 29.21%
                                                                               over 2009. In 2010, the company recorded an
Fax                                      N/A                                   operating margin of 19.38%, as against 23.46% in
                                                                               2009.
Website                                  www.fosun-international.com

Ticker Symbol, Stock Exchange            00656, Hong Kong Stock Exchange       Revenue and Margins

Number of Employees                      30,000

Fiscal Year End                          December

Revenue (in US$ million)                 6,584.62

Revenue (in CNY million)                 44,643.70




SWOT Analysis
                                                                               Return on Equity
Strengths                                Weaknesses
                                                                               The company recorded a return on equity (ROE) of
                                         Dependency on subsidiaries limiting   14.15% for 2010, as compared to its peers, Shougang
Diluted revenue generating sources
                                         direct control                        Concord Grand (Group) Limited (Ticker: 0730),
                                         Geographic Concentration of           Maanshan Iron & Steel Co. Ltd. (Ticker: 600808) and
Market recognition                                                             American Oriental Bioengineering, Inc. (Ticker: AOB),
                                         Revenues
                                                                               which recorded ROEs of 17.02%, 4.04% and 3.80%
Optimized source of financing            Overdependence on single segment      respectively. The company reported a net profit
                                                                               margin of 19.38% in 2010.
Wide range of business operations
                                                                               Return on Equity
Opportunities                            Threats

Favourable government policies           Fake websites in the company’s name

Global capacity building and strategic
                                         Volatile steel prices
investments

Strategic partnerships




                                                                               Liquidity Position

                                                                               The company reported a current ratio of 1.20 in 2010,
                                                                               as compared to its peers, Shougang Concord Grand
                                                                               (Group) Limited, Maanshan Iron & Steel Co. Ltd. and
                                                                               American Oriental Bioengineering, Inc., which
                                                                               recorded current ratios of 1.50, 1.05 and 4.68
                                                                               respectively. As of December 2010, the company
                                                                               recorded cash and short-term investments of worth
                                                                               US$3,862.97 million, against US$3,254.70 million
                                                                               current debt. The company reported a debt to equity
                                                                               ratio of 1.61 in 2010 as compared to its peers,
                                                                               Shougang Concord Grand (Group) Limited,
                                                                               Maanshan Iron & Steel Co. Ltd. and American
                                                                               Oriental Bioengineering, Inc., which recorded debt to
                                                                               equity ratios of 0.89, 0.97 and 0.29 respectively.




___________________________________________________________________________________________

Fosun International Limited - SWOT Profile                                                                            Page 1
Fosun International Limited

_________________________________________________________________________________


TABLE OF CONTENTS

1     Business Analysis ................................................................................................................................... 5
    1.1       Company Overview ................................................................................................................................................5
    1.2       Business Description ..............................................................................................................................................5
    1.3       Major Products and Services .................................................................................................................................6
2     Analysis of Key Performance Indicators ............................................................................................... 7
    2.1       Five Year Snapshot: Overview of Financial and Operational Performance Indicators ..........................................7
    2.2       Key Financial Performance Indicators .................................................................................................................10
      2.2.1       Revenue and Operating Profit .........................................................................................................................10
      2.2.2       Asset, Liabilities and Capex .............................................................................................................................11
      2.2.3       Net Debt vs. Gearing Ratio ..............................................................................................................................12
      2.2.4       Operational Efficiency ......................................................................................................................................13
      2.2.5       Solvency ..........................................................................................................................................................14
      2.2.6       Valuation ..........................................................................................................................................................15
    2.3       Competitive Benchmarking ..................................................................................................................................16
      2.3.1       Market Capitalization .......................................................................................................................................16
      2.3.2       Efficiency ..........................................................................................................................................................17
      2.3.3       Capital Expenditure..........................................................................................................................................18
      2.3.4       Valuation ..........................................................................................................................................................19
      2.3.5       Turnover – Inventory and Asset .......................................................................................................................20
      2.3.6       Liquidity ............................................................................................................................................................21
3     Recent Developments ................
				
DOCUMENT INFO
Description: ICD Research's "Fosun International Limited: Company Profile and SWOT Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
BUY THIS DOCUMENT NOW PRICE: $99 100% MONEY BACK GUARANTEED
PARTNER ICD Research
With emphasis on Insight, Consultancy and Delivery, iCD Research is a full-service, online market research agency. iCD Research is able to take advantage of all of the efficiencies and benefits that the Internet brings to offer proven research methodologies with fast turnaround and accurate results. iCD Research specialises in qualitative research for large finance, media, retail and entertainment clients. Market leaders in online focus groups, iCD Research has unleashed the full scale of the Internet to run focus groups across the globe for its major institutional clients. Utilising its sister organisation, The iD Factor, iCD Research also delivers strong quantitative research, ranging from ongoing consumer confidence studies through to consumer surveys throughout Europe and Asia. With its roots firmly in research, iCD Research doesn’t limit itself to only utilising online methods as the philosophy at the company is to match the methodology to the respondent. Yet the scale and speed of online research give iCD Research a cutting edge that has lead to tremendous, triple-figure percentage growth over the past two years. iCD Research is headquartered in London, with operational offices in the US and Australia to ensure that it is offering an unparalleled 24 hour service to its clients.